Loading stock data…
$74.44-0.28 (-0.37%)
Utah Medical Products, Inc.
Utah Medical Products, Inc. in the Healthcare sector is trading at $74.44 with a market capitalization of $220M. The stock is currently near its 52-week high of $76.89, remaining 11.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.53M↓ | $8.72M↓ | $9.04M↓ | $9.81M↓ | $9.95M |
| Gross Profit | $4.76M↓ | $5.28M↑ | $5.26M↓ | $5.60M↑ | $5.59M |
| Operating Income | $2.65M↓ | $3.01M↑ | $2.44M↓ | $2.61M↓ | $3.20M |
| Net Income | $2.69M↑ | $2.60M↑ | $2.57M↓ | $2.63M↓ | $3.05M |
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HO...